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Introduction Acetaminophen (APAP; N-acetyl-p-aminophenol) , a commonly used analgesic/antipyretic drug, is believed to be safe at therapeutic doses. However in overdose it produces a centrilobular hepatic necrosis. APAP-induced toxicity occurs by initial hepatic metabolism of APAP by cytochrome P450 to the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) (Dahlin et al., 1984) . Following a therapeutic dose NAPQI is efficiently detoxified by glutathione (GSH) but when taken in overdose NAPQI reacts with GSH leading to its depletion (Mitchell et al., 1973 ) and the metabolite covalently binds to hepatic cellular proteins to form 3-(cystein-S-yl)-acetaminophen adducts (APAP-Cys ) (Hoffmann et al., 1985) . These events are followed by oxidative stress, and toxicity has been postulated to be by oxidative stress. Previous studies have implicated the role of peroxynitrite, a reactive nitrogen species formed from nitric oxide and superoxide, in the development of oxidative stress. Peroxynitrite is both a nitrating agent and an oxidizing agent. Immunohistochemical analysis of livers from APAP treated mice indicated that nitrated proteins were co-localized with APAP-protein adducts in the hepatocytes of the centrilobular regions undergoing necrosis (Hinson et al., 1998) . Since iNOS is known to be in hepatocytes and Kupffer cells (Stolz et al., 2002) it was initially postulated to be the source of NO leading to peroxynitrite. However, APAP was found to be equally hepatotoxic in iNOS knockout mice and wildtype mice in two different laboratories (Michael et al., 2001; Bourdi et al., 2007) . Moreover, a pharmacological inhibitor of iNOS, aminoguanidine, did not decrease APAP hepatotoxicity in mice (Hinson et al., 2002) . These data suggested that iNOS was not important in development of toxicity in the wildtype mice.
To further understand the mechanism of APAP toxicity and the source of NO, our laboratory examined mechanisms of APAP toxicity in hepatocyte suspension assay. In freshly isolated This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 14, 2011 as DOI: 10.1124 at ASPET Journals on November 5, 2017 jpet.aspetjournals.org Downloaded from mouse hepatocytes APAP toxicity occurs in two phases. There is an initial metabolism phase (0-2 h) which is characterized by GSH depletion and covalent binding to proteins, but little toxicity.
Subsequent washing of the hepatocytes to remove APAP and incubation with media alone results in toxicity in the reincubation phase (3-5 h) (Boobis et al., 1986; Grewal and Racz, 1993) . We found that APAP toxicity occurred with mitochondrial permeability transition (MPT) (Reid et al., 2005) . Likewise APAP toxicity was reported by others to occur with MPT in cultured hepatocytes (Kon et al., 2004) . MPT is an abrupt increase in the permeability of the inner mitochondrial membrane to ions and small molecular weight solutes. It is promoted by oxidative stress and calcium and leads to a large increase in oxidative stress. MPT occurs with the loss of the ability of the mitochondria to produce ATP, a lethal event for the cell (Byrne et al., 1999; Zorov et al., 2000) . In the hepatocyte suspension assay we showed that the MPT inhibitor cyclosporine A and the antioxidant N-acetylcysteine added in the reincubation phase blocked toxicity, loss of mitochondrial membrane potential, the large increase in oxidative stress (2',7'-dichlorofluorescin (DCFH 2 ) oxidation), and MPT (Reid et al., 2005) .
Subsequently, we examined the role of peroxynitrite in the increased oxidative stress in APAP toxicity in the hepatocyte suspension assay. It was shown that APAP toxicity was associated with increased nitration of proteins. Toxicity, protein nitration, loss of mitochondrial membrane JPET # 184192 6 increased NO formation which reacts with superoxide to form peroxynitrite followed by nitration of proteins.
In our very recent work we have investigated the role of mitochondrial manganese superoxide dismutase (MnSOD; SOD2) in APAP toxicity (Agarwal et al., 2011) . It was shown that hepatic MnSOD activity was inhibited and the protein was nitrated early in the course of APAP toxicity.
Inhibition of activity correlated with the relative amount of nitration of MnSOD (Agarwal et al., 2011 ). This protein was previously shown to be nitrated and inactivated during renal transplant injury (MacMillan-Crow et al., 1996) (MacMillan-Crow and Cruthirds, 2001) .
In the present work we have investigated APAP-induced hepatotoxicity in nNOS knockout (KO) and wildtype (WT) mice. It was postulated that if nNOS present in hepatic mitochondria was mechanistically important in nitration leading to toxicity then nNOS KO mice would not develop the hepatic toxicity.
JPET # 184192 was withdrawn by cardiac puncture, and animals were subsequently euthanized under carbon dioxide followed by cervical dislocation. Livers were removed and weighed. Approximately 200 mg of liver was preserved in GSH homogenization buffer, a sample was preserved in buffered formalin, and the remaining tissue was snap frozen in liquid nitrogen and stored at -80° C for later analysis.
Serum Assays for Liver Toxicity. Toxicity was determined by the quantitation of serum alanine aminotransferase (ALT) and serum aspartate aminotransferase (AST) in the blood which occurred as a result of liver damage. Collected blood was allowed to coagulate at room temperature for at least 1 h, following centrifugation for 20 min at 3000g in a microcentrifuge.
The serum was collected and kept on ice until used to determine ALT and AST measurements with a colorimetric endpoint method utilizing diagnostic reagent kits (Pointe Scientific Inc., Canton, MI) according to manufacturer's protocol using a Roche Cobas Mira Classic Chemistry Analyzer (Roche Diagnostic systems, Inc., Branchburg, NJ).
Isolation of Liver mitochondria and cytoplasm. Liver mitochondrial and cytosolic fractions
were isolated by differential centrifugation following removal of the nuclear fraction. Briefly, livers were excised and homogenized in an isotonic buffer (10 mM HEPES, pH 7.8, 0.25 M Sucrose, 1 mM EGTA, 25 mM KCl) containing a protease inhibitor cocktail (Sigma-Aldrich, St.
Louis, MO) and 1 mM p-amidinophenyl methanesulfonyl fluoride (PMSF) using a Dounce homogenizer. Homogenate was centrifugation at 1,000 g for 10 min and the pellet representing nuclear fraction was removed. The resulting supernatant was centrifuged at 10,000 g for 20 min to separate the mitochondrial (pellet) and cytosolic fractions (supernatant).
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Hepatic Assays. MnSOD activity in liver homogenates was measured by a cytochrome c reduction method using 1 mM potassium cyanide to inactivate copper-zinc SOD (SOD1) and extracellular SOD (SOD3) as previously described (McCord and Fridovich, 1969) . GSH content in total liver homogenate, mitochondria and a cytosolic fraction was determined using a modification of the Elman procedure as previously described (Mitchell et al., 1973a) .
Histology. Livers samples were fixed in 10% neutral buffered formalin, processed and embedded into paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin (H&E). Slides were examined using an Olympus BX40 microscope under brightfield illumination. Hemorrhage, hepatocellular vacuolization, and hepatocellular necrosis were scored from 0 (no lesion) to 4 (severe change), and lobular localization was noted for all lesions.
APAP-cysteine protein adducts. APAP-cys adducts formed by covalent binding of NAPQI with liver proteins were measured by initial protease treatment of liver homogenates followed by a high performance liquid chromatography-electrochemical detection (HPLC-ECD) method as previously described (Muldrew et al., 2002) .
Western Blot Analysis. Liver homogenate preparation and Western blot analysis were performed as recently described (Agarwal et al., 2011) . Briefly, following separation using SDS-PAGE under reducing conditions, proteins were transferred to nitrocellulose membranes. Membranes were blocked 30 min for 4-HNE while overnight for NT in blocking buffer (5% milk in TBS, 0.1% 
Results

Effect of a toxic dose of APAP on biomarkers of toxicity in WT and nNOS KO mice.
To understand the potential role of nNOS in APAP toxicity, wildtype mice (WT) and nNOS knockout mice (KO) were administered a toxic dose of APAP (300 mg/kg, IP). Control mice were treated with saline. In a preliminary experiment it was determined that the APAP-induced increase in serum ALT levels were significantly delayed in KO mice. At 6 h serum ALT levels in the WT mice were 7854 ± 2751 IU/L whereas in the KO mice serum ALT was significantly less at 2431 ± 609 IU/L. However, by 8 h serum ALT levels were not different (4811 ± 572 IU/L in WT mice and 4850 ± 362 IU/L in KO mice). This experiment was repeated with more extensive analyses. Mice were again administered 300 mg/kg APAP and were sacrificed at 0.5, 1, 2, 4, 6, and 8 h after APAP administration. The development of hepatotoxicity was observed by determining serum ALT and AST levels and by histopathological evaluation. The time course for development of APAP-induced increase in serum levels of ALT is shown in Figure 1A .
Consistent with previous observations in WT mice, ALT levels were significantly increased at 6 and 8 h. In KO mice, ALT levels were not significantly increased until 8 h. By comparison in the KO mice, serum ALT levels paralleled those observed in the WT but appeared to be delayed.
The serum ALT levels at 6 h in the KO were significantly less than those observed in the WT.
Since an elevated serum AST level occurs with liver toxicity, AST levels were also determined in WT and KO mice ( Figure 1B ). In WT, AST levels were significantly increased at 4, 6, and 8
h. In KO mice, AST levels showed a time-dependent increase but were only significantly increased at 8 h. Comparing WT with KO mice, AST levels in WT were significantly higher than that in KO mice at 4 and 8 h.
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Hepatic glutathione (GSH) levels were determined to ascertain if there were differences in its depletion in the APAP-treated WT and KO mice. In both WT and KO mice GSH levels were maximally depleted by 0.5 h and remained maximally depleted at 1, 2 and 4 h. At 8 h, GSH levels had recovered to levels comparable to that of saline treated animals in the liver of both APAP-treated WT and KO mice. No significant differences in hepatic GSH levels were observed between WT and KO mice ( Figure 1C ). Covalent binding of the reactive metabolite NAPQI to protein as 3-cystein-S-yl-acetaminophen or APAP-cysteine adducts (APAP-Cys) is known to be a biomarker of toxicity that correlates with development of toxicity. Therefore, liver
homogenates from WT and KO mice were analyzed for APAP-Cys by HPLC-EC. Adducts were detected at all time points after administration of APAP ( Figure 1D ). Comparison of the relative amount of APAP covalent binding between WT and KO mice showed a parallel time-dependent increase in APAP-Cys formation with no significant difference between the two groups. These data indicate that APAP covalently bound to protein at equal rates and amounts in both WT and KO mice.
Comparison of a toxic dose of APAP to WT and nNOS KO mice on liver pathology.
Necrosis was most obvious in centrilobular regions at 4, 6, and 8 h following APAP treatment, and statistically significant differences between WT and KO mice were not apparent at any time point ( Figure 2B ) Necrosis was significantly elevated in WT animals compared to controls at 6 and 8 h. Hepatocellular vacuolization was first evident in 3 of 4 KO animals and 1 of 4 WT animals at 0.5 h, in centrilobular hepatocytes ( Figure 2C ). By 4 h, vacuolization was more prominent in midzonal hepatocytes in both groups. Hemorrhage was first noted in the midzonal region at 2 h in both WT and KO animals and became more severe and moved to the centrilobular location at later time points ( Figure 2D ). Hemorrhage scores were similar between This article has not been copyedited and formatted. The final version may differ from this version. Total additive pathology score for vacuolization, hemorrhage, and necrosis was significantly increased over 0 h at 4, 6, and 8 h for both KO and WT mice ( Figure 2E ). Although scores tended to be higher for WT mice at these time points, low sample size precluded statistical relevance. A subsequent experiment was performed to determine toxicity at 24 h. In this experiment all of the KO mice died (4) and one half of the WT mice (2 of 4) died. Thus, even though the toxicity was delayed it did not change the lethality of APAP at this dose.
To determine if delay in toxicity may be a result of a difference in mitochondrial GSH depletion another time-course experiment was performed. WT and KO mice were administered a toxic dose of APAP (300 mg/kg, IP) and were euthanized after 2 and 4 h. Control mice were treated with saline. Mitochondrial as well as cytosolic GSH levels were significantly depleted by 2 h and remained significantly depleted at 4 h in both WT and KO mice. GSH depletion was not significantly different for both mitochondrial and cytosolic fractions. Mitochondrial hepatic GSH levels were depleted by 70 ± 17% in KO mice at both 2 and 4 h and by 77 ± 13% in WT mice at both 2 and 4 h.
Effect of a toxic dose of APAP on activity and nitration of hepatic MnSOD in WT and nNOS KO mice.
To understand the role of nNOS and nitration of MnSOD in APAP toxicity, MnSOD activity and relative amounts were determined in liver homogenates from KO and WT mice (Figure 3) . We
This article has not been copyedited and formatted. The final version may differ from this version. JPET # 184192 previously reported that nitration of MnSOD results in a decrease in its activity (Agarwal et al., 2011) . In the liver homogenates of the WT mice MnSOD activity was significantly decreased at 1-2 h with a nadir at 2 h and subsequently increased to control level at 6 h and significantly increased by 8 h ( Figure 3A ). In the liver homogenates of the KO mice MnSOD activity was not significantly different from control level from 0 to 6 h; however, at 8 h it significantly decreased.
The amount of protein in the livers of WT mice did not change over the time course, but there was an increase in protein in the livers of the KO mice ( Figure 3B and Figure 3C ).
We previously presented evidence that decreased activity of hepatic MnSOD in APAP toxicity occurred with nitration. Thus, the data in Figure 3A showing greater MnSOD inactivation in WT mice compared to KO mice, suggested that there was significantly more MnSOD nitration in the liver of the APAP treated WT mice than in the KO mice. Therefore, additional analyses were performed to determine nitration of hepatic MnSOD in the WT and KO mice (Figure 4 ).
The combined liver homogenates of the 0, 2, 4, and 8 h groups of the WT and KO mice were analyzed for nitration of MnSOD on a single gel. As shown in Figure 4A there appears to be substantially more MnSOD nitration in the WT liver homogenate at 0, 2, 4, and 8 h compared to the liver homogenate from the KO mice. To confirm this finding Western blotting analyses were performed where all samples were analyzed on multiple blots with overlapping samples on the blots for comparison purposes ( Figure 4B ) and the data were statistically analyzed. MnSOD nitration in the WT mice was significantly greater than in the KO mice at 1-6 h. In the WT mice liver homogenates nitration of MnSOD was significantly increased by 1 h following APAP administration and remained significantly higher until 8 h in WT mice. However, in the KO mice a significant increase in hepatic MnSOD nitration was not observed until 6 h and remained significantly high at 8 h.
This article has not been copyedited and formatted. The final version may differ from this version. Effect of a toxic dose of APAP on oxidative stress in liver in WT and nNOS KO mice.
Oxidative stress also leads to lipid peroxidation, a major mechanism of cellular damage with some chemicals. 4-Hydroxynonenal (4-HNE) is a lipid peroxidation derived aldehyde that covalently binds to protein and has been utilized as a biomarker of lipid peroxidation (Esterbauer, 1996) . To determine the role of lipid peroxidation Western blot analysis for 4-HNE covalent binding was performed using anti-4-HNE. In the hepatic homogenates from the APAPtreated WT and KO mice two bands of 50 kDa and 39 kDa were detected in the control lane and APAP-treated samples in both WT and KO mice ( Figure 5A ). Densitometric analysis of the time course indicated an increase in 4-HNE protein adducts after APAP treatment in both WT and KO animals ( Figure 5B ). No significant increases with time were observed and there was no significant difference observed between WT and KO.
Assay of liver homogenates of WT and nNOS KO mice for total protein nitration.
To examine the possible effect of nNOS deletion on nitration of proteins other than MnSOD, additional Western blot analyses were performed on homogenates of the livers from the APAP treated WT and the KO mice. As shown in Figure 6 , only one 3-nitrotyrosine protein adduct with a molecular weight the same as that of MnSOD (MW 24 kDa) was detected in livers of APAP treated WT and KO mice. 
Discussion
The objective of the current study was to examine the role of nNOS in APAP-induced hepatotoxicity in mice by determining toxicity in nNOS KO mice and WT mice. Following APAP treatment hepatotoxicity was detected in both KO and WT mice. In the WT mice serum ALT levels were significantly increased at 6 and 8 h ( Figure 1A ) and AST was significantly increased at 4, 6, and 8 h ( Figure 1B ). However, in KO mice increases in ALT and AST were significantly delayed (Figure 1 ). These differences were not observed in the histopathological evaluation of toxicity ( Figure 2 ). Histopathological evaluation is the gold standard for toxicity;
however, it is not as sensitive a measure of toxicity as the appearance of transaminases in serum.
The finding that increases in serum ALT and AST levels were delayed suggests that the development of hepatic toxicity in the KO mice was delayed compared to the WT mice. Even though the hepatic toxicity as measured by transaminase elevations was delayed it did not convey a protective effect against lethality. In a 24 h experiment it was determined that all of the KO mice died; however, only one-half of the WT mice died.
Determination of the effect of APAP on MnSOD activity in liver of WT mice indicated that its activity was significantly decreased at 1 and 2 h followed by a recovery phase at 4-8 h ( Figure   3A ). These data are similar to what was previously observed (Agarwal et al., 2011) . MnSOD activity in the KO mice was not significantly altered until 8 h at which time it was significantly decreased ( Figure 3) . The relative amount of protein did not significantly change in the livers of the WT mice consistent with what we previously observed (Agarwal et al., 2011) ; however, the amount of protein in the livers of the KO mice increased slightly ( Figure 3B and Figure 3C ). In Figure 4A the combined liver homogenates in the time groups of 0, 2, 4, and 8 h of the WT and KO mice groups were analyzed on a single gel for nitrated proteins. There was significantly This article has not been copyedited and formatted. The final version may differ from this version. (Agarwal et al., 2011) which suggests a background level of peroxynitrite formation. The differences were statistically analyzed using multiple gels with overlapping samples ( Figure 4B ).
Following APAP administration nitration was significantly increased in the livers of WT mice at 1-8 h but was significantly increased in KO mice only at 6 and 8 h. There was significantly more nitration in the WT mice compared to KO mice at 1-6 h ( Figure 4B ). Thus, nNOS in hepatic mitochondria appears to be a major source of NO leading to nitration of MnSOD. However, nitration occurs in the hepatic mitochondria of KO mice which is consistent with NO formed by other NOS forms in the liver such as eNOS or iNOS (NO is freely diffusible). There was a significant increase in nitration of MnSOD in the liver homogenates of the KO mice at 6 and 8 h ( Figure 4B ). This increase coincides with a significant decrease in MnSOD activity at 8 h , 1985; Tirmenstein and Nelson 1989; Boobis et al., 1990) .
To more fully understand the oxidative stress in APAP toxicity hepatic lipid peroxidation in APAP toxicity in nNOS knockout mice was determined. Whereas peroxidation of lipids may occur by a Fenton reaction (ferrous plus peroxide), it may alos be mediated by peroxynitrite (Rubbo et al., 1994) . Lipid peroxidation has been reported to occur in APAP hepatotoxicity (Younes et al., 1986; Hinson et al., 2002) ; however, this is controversial (Kamiyama et al., 1993) . Lipid peroxidation in the APAP treated WT and KO mice was determined by assaying for 4-hydroxynonenal (4-HNE) covalent binding to liver homogenate. 4-Hydroxynonenal (4-HNE)
is produced by peroxidation of lipids and binds to nucleophilic groups on proteins. Covalent binding of 4-HNE to proteins is a biomarker of lipid peroxidation (Esterbauer, 1996; Waeg et al., 1996) . As shown in Figure 5 with time in liver homogenates of either WT or KO mice. Also, there were no significant differences observed between 4-HNE binding in livers of WT and KO mice. Thus, there is no evidence that nNOS contributes to this mechanism of oxidative stress in APAP toxicity.
Previously we reported one major nitrated protein, presumably MnSOD, in hepatic homogenates of APAP treated iNOS knockout and WT mice; however, we did observe a number of minor nitrated proteins (Michael et al., 2001) . Recently, Abdelmegeed et al., (2010) administered CYP2E1 KO mice and the corresponding WT mice a toxic dose of APAP and reported major nitrated proteins at, 60, 50 and 25 kDa, and a number of minor nitrated proteins. The relative amount of nitration correlated with toxicity. Thus, the finding of only one primary nitrated protein at 24 kDa (MnSOD) in this study was surprising. However, peroxynitrite is not only a nitrating agent it is an oxidizing agent and oxidative mechanisms may be important in toxicity.
For example, Schopfer et al. (Schopfer et al., 2000) have previously pointed out that electron transfer in the mitochondria via ubihydroquinone (ubiquinol) can be oxidized by peroxynitrite leading to formation of the semiquinone. The semiquinone can react with oxygen forming superoxide. This leads to disruption of electron transfer. By this mechanism initiation of toxicity would be a result of induction of NO synthesis which reacts with superoxide to form peroxynitrite and GSH depletion which normally detoxifies peroxynitrite. Thus, the reaction is self propagating. In support of this mechanism Amimoto et al. (Amimoto et al., 1995) showed a time-dependent decrease in hepatic reduced coenzyme Q9 and Q10 (ubihydroquinones) after administration of toxic doses of APAP to mice. Thus, both nitration and oxidation mechanisms may play an important role in APAP toxicity.
In conclusion, the finding that nitration of MnSOD is much greater in livers of APAP treated WT in the nNOS KO mice compared to the WT mice suggests that nNOS plays an important role in initiation of toxicity. However, the observation that there was a similar amount of toxicity by 8 h in the WT and KO mice suggests that although nitration and inactivation of MnSOD was delayed, alternative mechanisms are also important which may lead to toxicity following APAP treatment and these mechanisms are independent of nNOS. As discussed above one possible mechanism for activation of nNOS is by increased cytosolic calcium. In the absence of nNOS the increased cytosolic calcium may produce toxicity by other mechanisms. The postulated mechanism of APAP toxicity is presented in Figure 7 .
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